1,300
Views
9
CrossRef citations to date
0
Altmetric
Psychotherapeutics Column

The Physical Health of Individuals Receiving Antipsychotic Medication: A Qualitative Inquiry on Experiences and Needs

, PhD & , PhD

References

  • Alberti, K. G., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., … Smith, S., Jr (2009). Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; american heart association; world heart federation; International atherosclerosis society; And international association for the study of obesity. Circulation, 120(16), 1640–1645.
  • Altman, G. B. (2010). Medication administration. Fundamental & advanced nursing skills (3rd ed.). Clifton Park, New York: Delmar Cengage Learning.
  • Bainbridge, E., Gallagher, A., McDonald, G., McDonald, C., & Ahmed, M. (2011). General practitioners' attitudes on who should manage metabolic ysregulations associated with antipsychotics. Psychiatrist, 35, 213–215.
  • Barnes, T., Bhatti, S. F., Adroer, R., & Paton, C. (2015). Screening for the metabolic side effects of antipsychotic medication: Findings of a 6-year quality improvement programme in the UK. BMJ Open, 5, e007633–e007633. Available from
  • Barnes, T., Shingleton-Smith, A., & Paton, C. (2009). Antipsychotic long-acting injections: Prescribing practice in the UK. The British Journal of Psychiatry, 195(52), S37–S42.
  • Beecroft, N., Becker, T., Griffiths, G., Leese, M., Slade, M., & Thornicroft, G. (2001). Physical health care for people with severe mental illness: The role of the general practitioner (GP). Journal of Mental Health, 10(1), 53–61.
  • Blanner Kristiansen, C., Juel, A., Vinther Hansen, M., Hansen, A. M., Kilian, R., & Hjorth, P. (2015). Promoting physical health in severe mental illness: Patient and staff perspective. Acta Psychiatrica Scandinavica, 132(6), 470–478.
  • Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77–101.
  • Bressington, D., Mui, J., Mei, L. T., Gray, R., Cheung, E. F. C., & Wai, T. C. (2016). Cardiometabolic health, prescribed antipsychotics and health-related quality of life in people with schizophrenia-spectrum disorders: A cross-sectional study. BMC Psychiatry, 16, 1–14.
  • Chang, E. T., Wells, K. B., Young, A. S., Stockdale, S., Johnson, M. D., Fickel, J. J., Jou, K., & Rubenstein, L. V. (2014). The anatomy of primary care and mental health clinician communication: A quality improvement case study. Journal of General Internal Medicine, 29, 598–606.
  • Correll, C. U., Druss, B. G., Lombardo, I., O'Gorman, C., Harnett, J. P., & Sanders, K. N. (2010). Findings of a U.S. national cardiometabolic screening program among 10,084 psychiatric outpatients. Psychiatric Services, 61, 892–898. doi:10.1176/ps.2010.61.9.892.
  • Correll, C. U., Solmi, M., Veronese, N., Bortolato, B., Rosson, S., Santonastaso, P., … Stubbs, B. (2017). Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: A large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry: Official Journal of the World Psychiatric Association (WPA), 16(2), 163–180. doi:10.1002/wps.20420.
  • De Hert, M., Dekker, J. M., Wood, D., Kahl, K. G., Holt, R. I. G., & Moller, K. J. (2009). Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Associatin supported by the European Association for the Study of Diabetes and the European Society of Cardiology. European Psychiatry, 24, 412–424. doi:10.1016/j.eurpsy.2009.01.005.
  • Department of Health and Children. (2006). A Vision for Change: Report of the expert group on mental health policy. The Stationery Office, Dublin, Ireland.
  • Dobbie, M., & Mellor, D. (2008). Chronic illness and its impact: Considerations for psychologists. Psychology, Health & Medicine, 13(5), 583–590. doi:10.1080/13548500801983041.
  • Dobel-Ober, D., & Brimblecombe, N. (2016). National survey of nurse prescribing in mental health services; A follow-up 6 years on. Journal of Psychiatric & Mental Health Nursing, 23(6), 378–386. doi:10.1111/jpm.12329.
  • Falloon, R. H. (1984). Developing and maintaining adherence to long-term drug-taking regimens. Schizophrenia Bulletin, 10, 412–417. doi:10.1093/schbul/10.3.412.
  • Feeney, L., Kelly, F., Lee, J., Kelly, E., McLaughlin, S., & O'Boyle, H. (2007). Point prevalence of diabetes, obesity, hyperlipidemia, hypertension and smoking in outpatients on clozapine. Irish Journal of Psychological Medicine, 24(2), 59–61. doi:10.1017/S0790966700010247.
  • Fenton, W. S., Blyler, C., & Heinssen, R. K. (1997). Determinants of medication compliance in schizophrenia: Empirical and clinical findings. Schizophrenia Bulletin, 23, 637–651. doi:10.1093/schbul/23.4.637.
  • Fleischhacker, W. W. (2009). Second-generation antipsychotic long-acting injections: Systematic review. The British Journal of Psychiatry.Supplement, 52, S29–S36. doi:10.1192/bjp.195.52.s29.
  • Glasper, A. (2016). Caring for adults with severe mental illness and physical health problems. British Journal of Nursing, 25(22), 1266–1267. doi:10.12968/bjon.2016.25.22.1266.
  • Hahn, C. (2008). Doing qualitative research – using your computer. London: SAGE.
  • Happell, B., Davies, C., & Scott, D. (2012). Health behaviour interventions to improve physical health in individuals diagnosed with a mental illness: A systematic review. International Journal of Mental Health Nursing, 21(3), 236–247. doi:10.1111/j.1447-0349.2012.00816.x.
  • Healy, D. (2012). Pharmagedon. Los Angeles: University of California Press.
  • Healy, D. (2009). Psychiatric drugs explained (5th ed). London, UK.: Churchill Livingstoone Elsevier.
  • Holt, R. I. G. (2012). Cardiovascular disease and diabetes in people with severe mental illness: Causes consequences and pragmatic management. Primary Care Cardiovascular Journal (PCCJ), 5(2), 81–85.
  • Jang, J., Futeran, S., Large, M., & Curtis, J. (2015). An audit of general practitioner involvement in public community mental health care. Australasian Psychiatry, 23(5), 571–574. doi:10.1177/1039856215592479.
  • Jones, S., Howard, L., & Thornicroft, G. (2008). ‘Diagnostic overshadowing’: Worse physical health care for people with mental illness. Acta Psychiatrica Scandinavica, 118(3), 169–171. doi:10.1111/j.1600-0447.2008.01211.x.
  • Jonikas, J., Cook, J., Razzano, L., Steigman, P., Hamilton, M., Swarbrick, M., & Santos, A. (2016). Associations between gender and obesity among adults with mental illnesses in a community health screening study. Community Mental Health Journal, 52(4), 406–415. doi:10.1007/s10597-015-9965-2.
  • Manu, P., Dima, L., Shulman, M., Vancampfort, D., De Hert, M., & Correll, C. U. (2015). Weight gain and obesity in schizophrenia: Epidemiology, pathobiology, and management. Acta Psychiatrica Scandinavica, 132(2), 97–108. doi:10.1111/acps.12445.
  • Martin, A., Neale, E. P., Batterham, M., & Tapsell, L. C. (2016). Identifying metabolic syndrome in a clinical cohort: Implications for prevention of chronic disease. Preventive Medicine Reports, 4, 502–506. doi:10.1016/j.pmedr.2016.09.007.
  • McCabe, M. P., & Leas, L. (2008). A qualitative study of primary health care access, barriers and satisfaction among people with mental illness. Psychology, Health & Medicine, 13(3), 303–312. doi:10.1080/13548500701473952.
  • McCann, T. V., Deans, C., Clark, E., & Lu, S. (2008). A comparative study of antipsychotic medication taking in people with schizophrenia. International Journal of Mental Health Nursing, 17, 428–438. doi:10.1111/j.1447-0349.2008.00561.x.
  • McDaid, T. M., & Smyth, S. (2015). Metabolic abnormalities among people diagnosed with schizophrenia: A literature review and implications for mental health nurses. Journal of Psychiatric & Mental Health Nursing, 22(3), 157–170. doi:10.1111/jpm.12185.
  • Mitchell, A. J., Delaffon, V., Vancampfort, D., Correll, C. U., & De Hert, M. (2012). Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: Systematic review and meta-analysis of screening practices. Psychological Medicine, 42(1), 125–147. doi:10.1017/S003329171100105X.
  • Mizock, L. (2012). The double stigma of obesity and serious mental illnesses: Promoting health and recovery. Psychiatric Rehabilitation Journal, 35(6), 466–469.
  • Morrison, P., Meehan, T., & Stomski, N. J. (2015). Living with antipsychotic medication side-effects: The experience of australian mental health consumers. International Journal of Mental Health Nursing, 24(3), 253–261. doi:10.1111/inm.12110.
  • Nash, M. (2013). Diagnostic overshadowing: A potential barrier to physical health care for mental health service users. Mental Health Practice, 17(4), 22–26. doi:10.7748/mhp2013.12.17.4.22.e862.
  • Newman, D., O'Reilly, P., Siew, H. L., & Kennedy, C. (2017). Challenges in accessing and interviewing participants with severe mental illness. Nurse Researcher, 25(1), 37–42. doi:10.7748/nr.2017.e1443.
  • Ohlsen, R. I., Atakan, Z., Smith, S., Sood, P., Papanastasiou, E., Featherman, A., O'Brien, C., Greenwood, K., Ismail, K., Todd, G., Mushore, M., Stahl, D., Murray, R. and Gaughran, F. (2012). P-1281 - The impact RCT: prevalence of metabolic syndrome in a severely mentally ill cohort European Psychiatry, 27(S1), 1.
  • Pack, S. (2009). Poor physical health and mortality in patients with schizophrenia. Nursing Standard, 23(21), 41–45. doi:10.7748/ns.23.21.41.s50.
  • Pastore, P., Griswold, K., Homish, G., & Watkins, R. (2013). Family Practice Enhancements for Patients with Severe Mental Illness. Community Mental Health Journal, 49(2) 172–177.
  • Qin, L., Knol, M. J., Corpeleijn, E., & Stolk, R. P. (2010). Does physical activity modify the risk of obesity for type 2 diabetes: A review of epidemiological data. European Journal of Epidemiology, 25(1), 5–12. doi:10.1007/s10654-009-9395-y.
  • Rogers, A., Day, J., Williams, B., Randall, F., Wood, P., Healy, D., & Bentall, R. (1998). The meaning and management of neuroleptic medication: A study of patients with a diagnosis of schizophrenia. Journal of Social Science and Medicine, 47(9), 1313–1323. doi:10.1016/S0277-9536(98)00209-3.
  • Rollins, A. L., Henry, N. H., Quash, A. M., Benbow, K., Bonfils, K. A., Hedrick, H., … Wright-Berryman, J. (2017). Managing physical and mental health conditions: Consumer perspectives on integrated care. Social Work in Mental Health, 15(1), 66–79. doi:10.1080/15332985.2016.1173160.
  • Ross, J. D., Clarke, A., & Kettles, A. M. (2014). Mental health nurse prescribing: Using a constructivist approach to investigate the nurse-patient relationship. Journal of Psychiatric & Mental Health Nursing, 21(1), 1–10. doi:10.1111/jpm.12039.
  • Scott, D., & Happell, B. (2011). The high prevalence of poor physical health and unhealthy lifestyle behaviours in individuals with severe mental illness. Issues in Mental Health Nursing, 32(9), 589–597. doi:10.3109/01612840.2011.569846.
  • Stanley, S. H., & Laugharne, J. D. E. (2012). Obesity, cardiovascular disease and type 2 diabetes in people with a mental illness: A need for primary health care. Australian Journal of Primary Health, 18(3), 258–264. doi:10.1071/PY11045.
  • Storch, J., Rodney, P., Pauly, B., Fulton, T. R., Stevenson, L., Newton, L., & Makaroff, K. S. (2009). Enhancing ethical climates in nursing work environments. Canadian Nurse, 105(3), 20–25.
  • Sung, K., Ryu, S., Lee, J., Lee, S., Cheong, E., Kim, J., … Byrne, C. D. (2016). All cause mortality and body mass index in a young asian occupational cohort without baseline metabolic syndrome components. International Journal of Cardiology, 224, 271–278. doi:10.1016/j.ijcard.2016.09.056.
  • Taylor, J., Böhnke, J. R., Wright, J., Kellar, I., Alderson, S. L., Hughes, T., … & Siddiqi, N. (2017). A core outcome set for evaluating self-management interventions in people with comorbid diabetes and severe mental illness: Study protocol for a modified delphi study and systematic review. Trials, 18, 1–9. doi:10.1186/s13063-017-1805-y.
  • Thornicroft, G., Rose, D., & Kassam, A. (2007). Discrimination in health care against people with mental illness. International Review of Psychiatry (Abingdon, England), 19(2), 113–122. doi:10.1080/09540260701278937.
  • Vancampfort, D., Wampers, M., & Mitchell, A. J. (2013). A meta-analysis of cardio-metabolic abnormalities in drug naïve, first-episode and multi-episode patients with schizophrenia versus general population controls. World Psychiatry, 12, 240–250. doi:10.1002/wps.20069.
  • Ward, T., Wynaden, D., & Heslop, K. (2017). Who is responsible for metabolic screening for mental health clients taking antipsychotic medications? International Journal of Mental Health Nursing, DOI: 10.1111/inm.12309
  • Weiden, P. J., Dixon, L., Frances, A., Appelbaum, P., Haas, G., & Rapkin, B. (1991). Neuroleptic noncompliance in schizophrenia. In C. C. Tamminga & S. C. Schulz (Eds.), Schizophrenia research: Advances in neuropsychiatry and psychopharmacology (pp. 285–296). New York: Raven Press.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.